U.S. market Open. Closes in 5 hours 2 minutes

LH | Laboratory Corporation of America Holdings Stock Overview

(Stock Exchange: NYSE)
Day's Range 228.25 - 234.53
52 Week Range 191.97 - 258.59
Beta 0.96
Implied Volatility 25.73%
IV Rank 53.98%
Day's Volume 788,668
Average Volume 617,332
Shares Outstanding 83,700,000
Market Cap 19,480,338,000
Sector Healthcare
Industry Medical - Diagnostics & Research
IPO Date 1990-03-29
Valuation
Profitability
Growth
Health
P/E Ratio 26.36
Forward P/E Ratio 11.44
EPS 8.83
1YR Price Target 260.00
Dividend Yield 1.25%
Dividend Per Share 2.91
Dividend ExDate 2022-11-16
Dividend PayDate 2022-12-09
Employees 67,000
Country USA
Website LH
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
LH's peers: CRL, ICLR, IQV, DGX, WAT, UHS, HUM, HOLX, MEDP, MTD, RVTY
*Chart delayed
Analyzing fundamentals for LH we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is very poor, Growth is good and Health is passable. For more detailed analysis please see LH Fundamentals page.

Watching at LH technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on LH Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙